Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting

scientific article

Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/PROTEIN/10.8.959
P698PubMed publication ID9415446
P5875ResearchGate publication ID13815698

P50authorAndreas PlückthunQ23057697
P2093author name stringJung S
P433issue8
P921main subjectantibodyQ79460
P304page(s)959-966
P577publication date1997-08-01
P1433published inProtein Engineering Design and SelectionQ15762396
P1476titleImproving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting
P478volume10

Reverse relations

cites work (P2860)
Q33307001A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm
Q33224274A mutation designed to alter crystal packing permits structural analysis of a tight-binding fluorescein-scFv complex
Q30810608An alternating selection strategy for cloning phage display antibodies
Q56891850An integrated approach to extreme thermostabilization and affinity maturation of an antibody
Q47937927An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly
Q39016494Antibody Fragments as Probe in Biosensor Development
Q56896775Antibody engineering
Q39793519Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts
Q43052895Characterization of the 4D5Flu single-chain antibody with a stimulus-responsive elastin-like peptide linker: a potential reporter of peptide linker conformation
Q57840014Characterizing the functionality of recombinant T-cell receptors in vitro: a pMHC tetramer based approach
Q47158894Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv.
Q38323531Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor
Q33789036Conversion of scFv peptide-binding specificity for crystal chaperone development
Q30406181Crystallization chaperone strategies for membrane proteins
Q90212096Design and Production of Bispecific Antibodies
Q33283622Design of synthetic antibody libraries
Q34630307Designing immunotoxins for cancer therapy.
Q30845963Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework
Q30923970Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
Q40176311Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.
Q51246263Engineering Antibodies for Biosensor Technologies.
Q47613006Engineering stable cytoplasmic intrabodies with designed specificity
Q36130655Engineering tandem single-chain Fv as cell surface reporters with enhanced properties of fluorescence detection
Q53627592Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection.
Q33659675Exploiting antibody-based technologies to manage environmental pollution
Q34983046Expression and folding of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm
Q90668587Expression of anti-tumor recombinant IgG- and IgE-like genes in eukaryotic cells
Q40903643Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7.
Q43887450Forces and energetics of hapten-antibody dissociation: a biased molecular dynamics simulation study
Q78454268Functional improvement of antibody fragments using a novel phage coat protein III fusion system
Q79182590Generation of a highly stable, internalizing anti‐CD22 single‐chain Fv fragment for targeting non‐Hodgkin's lymphoma
Q35748485Increased Fab thermoresistance via VH-targeted directed evolution
Q27636955Increasing protein stability by polar surface residues: domain-wide consequences of interactions within a loop
Q26740106Intracellular targeting with engineered proteins
Q30944840Methods for generating multivalent and bispecific antibody fragments
Q33518649Oligovalent Fab display on M13 phage improved by directed evolution
Q30712277Phage versus phagemid libraries for generation of human monoclonal antibodies.
Q30155518Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study
Q35024068Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line
Q42854245Rational engineering of antibody therapeutics targeting multiple oncogene pathways
Q40196625Role of native-state topology in the stabilization of intracellular antibodies
Q38332125Selecting proteins with improved stability by a phage-based method
Q32066800Selection for a periplasmic factor improving phage display and functional periplasmic expression
Q33249034Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display
Q36639059Single-domain antibody fragments with high conformational stability
Q35764163Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach
Q26859495Stability engineering of the human antibody repertoire
Q41609499Structure-based design of supercharged, highly thermoresistant antibodies
Q42662047The Skp chaperone helps fold soluble proteins in vitro by inhibiting aggregation.
Q56038596The first constant domain (CH1 and CL) of an antibody used as heterodimerization domain for bispecific miniantibodies
Q30854397The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines.
Q33586057The selection of intracellular antibodies.
Q37392835Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates
Q34045831Versatile strategy for controlling the specificity and activity of engineered T cells

Search more.